Trump is considering a radical to lead FDA. That’s dangerous for public health
By Ed Silverman,
STAT
| 12. 12. 2016
Imagine being prescribed a medicine when neither your doctor nor the manufacturer has any clue whether it will actually work — because the government never required it to be tested for effectiveness.
That’s not how things are done now, because federal law requires drugs to undergo clinical trial testing to gauge benefits and risks. But the incoming Trump administration may seek to undo a decades-old standard of evaluating drugs for effectiveness — to the detriment of every American who takes a prescription medicine.
One of two people being vetted as the next Food and Drug Administration commissioner gave a speech two years ago in which he suggested the agency require only safety testing for new drugs. After that, good luck.
Imagine being prescribed a medicine when neither your doctor nor the manufacturer has any clue whether it will actually work — because the government never required it to be tested for effectiveness.
That’s not how things are done now, because federal law requires drugs to undergo clinical trial testing to gauge benefits and risks. But the incoming Trump administration may seek to...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Tory Shepherd, The Guardian | 07.17.2026
Over eight years, Ethan and his wife went through nine rounds of IVF in Melbourne.
They travelled to Spain for two more, without success.
“I thought maybe the universe had decided we’re not supposed to have kids,” says Ethan, who...
By Oscar Lopez, The Guardian | 07.19.2026
Diogo Amaro met his future husband, Loup, in Paris and from the first date, he made one thing clear: he wanted to have children.
“Right off the bat, I was like: ‘If I’m going to be in a relationship with...
By Emily Baumgaetner Nunn, The New York Times | 07.20.2026
The National Institutes of Health recently announced a remarkable achievement: the world’s largest database of human genomes, a repository of information that the agency says will help usher in a new era in personalized medicine.
Scientists are already developing clinical...